相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Efficacy of Metformin in Patients With Breast Cancer Receiving Chemotherapy or Endocrine Therapy: Systematic Review and Meta-analysis
Kayoko Morio et al.
ANNALS OF PHARMACOTHERAPY (2022)
Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study
Maarten J. Wensink et al.
ANNALS OF INTERNAL MEDICINE (2022)
Metformin and survival of women with breast cancer: A meta-analysis of randomized controlled trials
Qiandan Wang et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2022)
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer The MA.32 Randomized Clinical Trial
Pamela J. Goodwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer
Hyunwoo Kwon et al.
SCIENCE IMMUNOLOGY (2022)
Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy
S. Roy et al.
CLINICAL ONCOLOGY (2021)
The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data
Jihun Kang et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Biphasic effect of metformin on human cardiac energetics
Larisa Emelyanova et al.
TRANSLATIONAL RESEARCH (2021)
Metformin-enhances resilience via hormesis
Edward J. Calabrese et al.
AGEING RESEARCH REVIEWS (2021)
Randomized phase II study of platinum-based chemotherapy plus controlled diet with or without metformin in patients with advanced non-small cell lung cancer
Youngjoo Lee et al.
LUNG CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
Yun Hu et al.
DIABETES CARE (2021)
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer
Marc Pujalte Martin et al.
CLINICAL GENITOURINARY CANCER (2021)
Repurposing metformin as anticancer drug: Randomized controlled trial in advanced prostate cancer (MANSMED)
Reham Alghandour et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer The NRG-LU001 Phase 2 Randomized Clinical Trial
Heath Skinner et al.
JAMA ONCOLOGY (2021)
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer The OCOG-ALMERA Randomized Clinical Trial
Theodoros Tsakiridis et al.
JAMA ONCOLOGY (2021)
The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Yongchao Zhang et al.
ONCOIMMUNOLOGY (2021)
Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination
Shereen El Shorbagy et al.
JOURNAL OF GASTROINTESTINAL CANCER (2021)
Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types
Zishan Wang et al.
NUCLEIC ACIDS RESEARCH (2020)
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study
V. L. Bae-Jump et al.
GYNECOLOGIC ONCOLOGY (2020)
Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines
Gretchen Collins et al.
REPRODUCTIVE SCIENCES (2019)
Metformin protects PC12 cells and hippocampal neurons from H2O 2-induced oxidative damage through activation of AMPK pathway
Xia Zhao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways
Liwei Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis
Ting-Ting Gong et al.
FRONTIERS IN ONCOLOGY (2019)
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial
Li Li et al.
CLINICAL CANCER RESEARCH (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma A Phase 2 Randomized Clinical Trial
Oscar Arrieta et al.
JAMA ONCOLOGY (2019)
Metformin plus first-line chemotherapy versus chemotherapy alone in the treatment of epithelial ovarian cancer: a prospective open-label pilot trial
Ya Zheng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Metformin Use and Kidney Cancer Survival Outcomes A Systematic Review and Meta-Analysis
Madhur Nayan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases
Fang Xiong et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
O. Nanni et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy
Isabel Pimentel et al.
BREAST (2019)
Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism
Ahmed Alshawi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials
Zhi-Jiang Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
Differential Expression Patterns of Glycolytic Enzymes and Mitochondria-Dependent Apoptosis in PCOS Patients with Endometrial Hyperplasia, an Early Hallmark of Endometrial Cancer, In Vivo and the Impact of Metformin In Vitro
Tao Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Concentration-dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells
Silvia Ravera et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Effect of metformin on dental pulp stem cells attachment, proliferation and differentiation cultured on biphasic bone substitutes
Behzad Houshmand et al.
ARCHIVES OF ORAL BIOLOGY (2018)
Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners
Dian Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats
Min Hu et al.
JOURNAL OF ENDOCRINOLOGY (2018)
LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations
Yongsheng Li et al.
NUCLEIC ACIDS RESEARCH (2018)
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naive Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
Kristen A. Marrone et al.
ONCOLOGIST (2018)
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial
Melanie Royce et al.
JAMA ONCOLOGY (2018)
Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
Xian Shen et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Combination of Metformin and Chemotherapy Decreases the Recurrence Rates of Epithelial Ovarian Cancers: A Randomized Clinical Trial
Bahareh Hamedi et al.
INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (2018)
The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysis
Jianrong Zhang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
Andrea Casadei Gardini et al.
EUROPEAN JOURNAL OF CANCER (2017)
A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer
Yannan Zhao et al.
ONCOTARGET (2017)
Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer
Yongsheng Li et al.
CELL REPORTS (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Michele Reni et al.
CLINICAL CANCER RESEARCH (2016)
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
C. Coyle et al.
ANNALS OF ONCOLOGY (2016)
Metformin may protect nondiabetic breast cancer women from metastasis
Sahar Mohammed EL-Haggar et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Gadi Shlomai et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Metformin-induced protection against oxidative stress is associated with AKT/mTOR restoration in PC12 cells
Behzad Khallaghi et al.
LIFE SCIENCES (2016)
Metformin Addition to Chemotherapy in Stage IV Non-Small Cell Lung Cancer: an Open Label Randomized Controlled Study
Rana Sayed et al.
Asian Pacific Journal of Cancer Prevention (2015)
Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes
Hengyi Chen et al.
CANCER LETTERS (2015)
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
Andrea Casadei Gardini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer
A. M. Joshua et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats
Mustafa Tas et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Metformin Increases Mitochondrial Energy Formation in L6 Muscle Cell Cultures
Veeravenkata S. Vytla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons
Ikram Ullah et al.
BMC NEUROSCIENCE (2012)
Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
Jennifer A. Hirst et al.
DIABETES CARE (2012)
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
R. J. Stevens et al.
DIABETOLOGIA (2012)
Metformin exposure affects human and mouse fetal testicular cells
P. Tartarin et al.
HUMAN REPRODUCTION (2012)
Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer
Chao Gu et al.
CANCER SCIENCE (2011)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effect of metformin on nitric oxide synthase in genetically obese (ob/ob) mice
VB Kumar et al.
LIFE SCIENCES (2001)
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
T Simoncini et al.
NATURE (2000)
分享论文
